Integral Molecular and Integrated BioTherapeutics Collaborate to Engineer Broadly Protective Ebolavirus Vaccines
PHILADELPHIA – A collaboration between Integral Molecular and Integrated BioTherapeutics (IBT), two biotechnology companies with deep expertise in virology, has resulted in engineered proteins that may enable next-generation vaccines with broad protection against Ebola and related viruses. With access to neutralizing Ebola antibodies discovered by IBT, Integral Molecular used Shotgun Mutagenesis—part of its GeneCanvas protein […]